Top Five Symptoms

At Carevive, we believe that understanding cancer symptoms is pivotal to improving the patient experience. In this video transcript, we unveil the top five cancer symptoms reported in our registries.

Topping the list is general pain, closely followed by numbness and tingling, fatigue, nausea, and decreased appetite. These insights gathered from real-world patients provide valuable data for better understanding drug tolerability, especially when compared to clinical trial populations.

Our Carevive Smart Data offers a transformative approach to cancer care, enabling healthcare providers to deliver personalized treatments and support based on comprehensive patient experiences. Reach out to us today to learn more about how our smart data can empower you in providing the best possible care for cancer patients. Together, let’s make a positive impact on cancer care worldwide.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…